MARKSANS PHARMA
Back to Income Statement
|
MARKSANS PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹314 Cr | ₹266 Cr | ₹185 Cr | ₹236 Cr | ₹117 Cr |
What is the latest Consolidated Net Profit of MARKSANS PHARMA ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹314 Cr |
Mar2023 | ₹266 Cr |
Mar2022 | ₹185 Cr |
Mar2021 | ₹236 Cr |
Mar2020 | ₹117 Cr |
How is Consolidated Net Profit of MARKSANS PHARMA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹314 Cr | 17.80 | |
Mar2023 | ₹266 Cr | 44.29 | |
Mar2022 | ₹185 Cr | -21.77 | |
Mar2021 | ₹236 Cr | 101.62 | |
Mar2020 | ₹117 Cr | - |
Compare Consolidated Net Profit of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹11,459.2 Cr | -4.5% | -12.9% | 62.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹437,135.0 Cr | 2.6% | -1.1% | 38.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹153,074.0 Cr | -3.8% | -1.9% | 60.1% | Stock Analytics | |
CIPLA | ₹114,019.0 Cr | -2.4% | -5.2% | 10.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,192.0 Cr | -5.9% | -9.6% | 14.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,256.3 Cr | -3.9% | -0.3% | 40.6% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | -4.5% |
-12.9% |
62.5% |
SENSEX | -0.6% |
-2.9% |
6.3% |
You may also like the below Video Courses